PROCESSA PHARMACEUTICALS, Inc. $30 Million OF COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 20th, 2021 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
